by Dan Roberts April 2002 AMD patients are benefitting from a new combination drug therapy being tested at the University of Texas Health Science Center at San Antonio (UTHSC). The therapy involves a combination of medicines which includes carbon dioxide, an element which dilates the blood vessels in the retina for the maintenance of proper [Read More]
